Examples of using Developing foetus in English and their translations into Portuguese
{-}
-
Medicine
-
Colloquial
-
Official
-
Financial
-
Ecclesiastic
-
Ecclesiastic
-
Computer
-
Official/political
Targretin may be harmful to a developing foetus.
Given that the potential risks to the developing foetus are unknown, women of child-bearing potential should use effective contraception.
The potential risk of treatment to the developing foetus is unknown.
Since alpha1-proteinase inhibitor is a normal component of human blood,recommended dose of this medicine is not expected to cause harm to the developing foetus.
It has serious effects on a developing foetus, and cannot be taken when pregnant.
Pregnancy and breast-feeding Targretin may be harmful to a developing foetus.
Women of childbearing potential:given that the potential risks to the developing foetus are unknown, women of childbearing potential should use effective contraception.
It is not known whether Cerezyme passes via the placenta to the developing foetus.
Based on its mechanism of action,this medicinal product may harm a developing foetus; therefore, women who are pregnant or may be pregnant should not handle it without protection, e.g., gloves.
Reproduction toxicity studies in female rats andrabbits have shown no effect on pregnancy or the developing foetus.
During pregnancy the mucus plug becomes thick and protects the developing foetus by sealing the endocervical canal once again.
Human IgG is known to cross the placental barrier, andpanitumumab may therefore be transmitted from the mother to the developing foetus.
In the event of pregnancy following Zalmoxis treatment adverse effect on pregnancy and the developing foetus are not expected as lymphocytes do not pass the placenta.
Human IgG1 is known to cross the placenta; therefore,necitumumab has the potential to be transmitted from the mother to the developing foetus.
With respect to pregnancy,EFSA noted that there was no risk to the developing foetus from exposure to phenylalanine derived from aspartame at the current ADI with the exception of women suffering from PKU.
Romiplostim is known to cross the placental barrier in rats andmay be transmitted from the mother to the developing foetus and stimulate foetal platelet production.
Human IgG4 is known to cross the placental barrier and nivolumab is an IgG4;therefore nivolumab has the potential to be transmitted from the mother to the developing foetus.
In pregnant women, overdoses of calcium andvitamin D should be avoided as permanent hypercalcaemia has been related to adverse effects on the developing foetus.
Human immunoglobulins G4(IgG4) are known to cross the placental barrier; therefore, being an IgG4,pembrolizumab has the potential to be transmitted from the mother to the developing foetus.
They look like partially developed foetuses.
This increases a women's risk of developing an ectopic pregnancy, which is when a foetus develops outside the womb, which can be extremely dangerous to the mother.